title: P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases.
authors.forename: D
authors.initials: D
authors.lastname: Damiani
authors.forename: M
authors.initials: M
authors.lastname: Michieli
authors.forename: A
authors.initials: A
authors.lastname: Michelutti
authors.forename: F
authors.initials: F
authors.lastname: Pea
authors.forename: M
authors.initials: M
authors.lastname: Baraldo
authors.forename: R
authors.initials: R
authors.lastname: Fanin
authors.forename: D
authors.initials: D
authors.lastname: Russo
authors.forename: M
authors.initials: M
authors.lastname: Furlanut
authors.forename: M
authors.initials: M
authors.lastname: Baccarani
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000502:physiology*; D000903:Antibiotics, Antineoplastic / Q000493:pharmacokinetics*; D016572:Cyclosporine / Q000008:administration & dosage*; D018432:Drug Resistance, Multiple; D006801:Humans; D015255:Idarubicin / Q000493:pharmacokinetics*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000378:metabolism*; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D008875:Middle Aged
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000903:Antibiotics, Antineoplastic; D016572:Cyclosporine; D015255:Idarubicin